-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Elevation Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
- Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.15M, a 36.9% increase year-over-year.
- Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.39M, a 13.4% decline year-over-year.
- Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.34M, a 4.02% increase from 2022.
- Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.21M, a 104% increase from 2021.
- Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.57M, a 2921% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)